KIROMIC BIOPHARMA, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02 Results of Operations and Financial Condition.

On August 13, 2021, Kiromic Biopharma, Inc. issued a press release announcing financial and corporate results for the three months ended June 30, 2021. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

The information disclosed under this Item 2.02, including Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.

Item 9.01 Financial Statements and Exhibit

(d) Exhibits.

The following exhibit is filed with this Current Report on Form 8-K:

Exhibit
Number     Description
  99.1       Press Release dated August 13, 2021

104        Cover Page Interactive Data File - the cover page interactive data file
           does not appear in the Interactive Data File because its XBRL tags are
           embedded within the Inline XBRL document

© Edgar Online, source Glimpses